Log in

Relevant bibliographies by topics / Instent restenosis / Journal articles

To see the other types of publications on this topic, follow the link: Instent restenosis.

Journal articles on the topic 'Instent restenosis'

Author: Grafiati

Published: 15 June 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Instent restenosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Praveen Kumar, M., S. Suresh Kumar, and T. Munusamy. "INSTENT RESTENOSIS WITH BIFURCATION STENTING." Indian Heart Journal 75 (December 2023): S60. http://dx.doi.org/10.1016/j.ihj.2023.11.126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chen, Yin, Shilian Hu, and Lei Wu. "Drug-eluting balloon for instent restenosis." Heart 99, no. 24 (2013): 1874.1–1874. http://dx.doi.org/10.1136/heartjnl-2013-304720.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bahl, Rahul, Andreas Indermuehle, Georg M. Froehlich, et al. "Drug-eluting balloon for instent restenosis." Heart 99, no. 24 (2013): 1874.2–1875. http://dx.doi.org/10.1136/heartjnl-2013-304722.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Gonzalez, Alberto J., Michael A. Drummond, R. Scott McCord, and H. Edward Garrett. "Carotid Endarterectomy for Treatment of Instent Restenosis." Journal of Vascular Surgery 52, no. 6 (2010): 1742. http://dx.doi.org/10.1016/j.jvs.2010.10.025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Exner, Markus, Schila Sabet, Wolfgang Mlekusch, et al. "High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting." Thrombosis and Haemostasis 92, no. 11 (2004): 1108–13. http://dx.doi.org/10.1160/th04-05-0311.

Full text

Abstract:

SummaryHigh heparin cofactor II (HCII) activity has recently been described to protect from coronary instent restenosis, presumably by inactivating thrombin in injured arteries. In this study, we investigated the association of HCII activity and restenosis after femoropopliteal stenting. We studied 63 consecutive patients with peripheral artery disease who underwent femoropopliteal stent implantation after initial failure of plain balloon angioplasty due to a significant residual stenosis (>30% lumen diameter reduction) or a flow limiting dissection. HCII activity was measured before stenti

APA, Harvard, Vancouver, ISO, and other styles

6

Dussaillant, Gaston R., Gary S. Mintz, Augusto D. Pichard, et al. "A serial volumetricintravascular ultrasound analysis of instent restenosis." Journal of the American College of Cardiology 27, no. 2 (1996): 362. http://dx.doi.org/10.1016/s0735-1097(96)82365-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Şabanoğlu, Cengiz, Esra Polat, and Elif İlkay Yüce. "The Association Between Coronary Instent Restenosis and Eosinophil/Monocyte Ratio." e-Journal of Cardiovascular Medicine 10, no. 3 (2022): 137–43. http://dx.doi.org/10.32596/ejcm.galenos.2022.2022-08-045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Akin, E., K. Knobloch, M. Pichlmaier, and A. Haverich. "Instent restenosis after carotid stenting necessitating open carotid surgical repair." European Journal of Cardio-Thoracic Surgery 26, no. 2 (2004): 442–43. http://dx.doi.org/10.1016/j.ejcts.2004.03.047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Tilara, Mandip, Rakesh Tirmale, and Sharad Jain. "Study of clinico-etiological profile of patients with instent restenosis." Indian Heart Journal 69 (November 2017): S62. http://dx.doi.org/10.1016/j.ihj.2017.09.181.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Judkins, C., A. Wilson, and P. Barlis. "A Presentation on Lipid and Protein Markers of Instent Restenosis." Heart, Lung and Circulation 25 (August 2016): S163. http://dx.doi.org/10.1016/j.hlc.2016.06.384.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Zeller, Thomas, Aljoscha Rastan, Uwe Schwarzwälder, et al. "Treatment of instent restenosis following stent-supported renal artery angioplasty." Catheterization and Cardiovascular Interventions 70, no. 3 (2007): 454–59. http://dx.doi.org/10.1002/ccd.21220.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Hassid, Babak, Arber Kodra, Michael C. Kim, et al. "SAFETY AND EFFICACY OF INTRACORONARY BRACHYTHERAPY PROTOCOL FOR RESISTANT INSTENT RESTENOSIS." Journal of the American College of Cardiology 79, no. 9 (2022): 849. http://dx.doi.org/10.1016/s0735-1097(22)01840-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Mastuda, Junji, Taishi Yonetsu, Tadashi Murai, et al. "COMPARISON BETWEEN ANGIOSCOPIC AND OPTICAL COHERENCE TOMOGRAPHIC ASSESSMENT OF INSTENT RESTENOSIS." Journal of the American College of Cardiology 69, no. 11 (2017): 298. http://dx.doi.org/10.1016/s0735-1097(17)33687-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Shah, J., M. Sebastian, N. Andrianopoulos, et al. "How should we treat drug eluting stent (DES) instent restenosis (ISR)?" Heart, Lung and Circulation 24 (2015): S277. http://dx.doi.org/10.1016/j.hlc.2015.06.389.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Engel, L., R. Adolf, I. Kringe, et al. "Identification Of Morphologic And Inflammatory Predictors Of Instent-Restenosis Using CCTA." Journal of Cardiovascular Computed Tomography 17, no. 4 (2023): S18. http://dx.doi.org/10.1016/j.jcct.2023.05.050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Siddiqui, Taha, Raiyan Ali, Shahan Haseeb, et al. "D-99 | The Burden of Instent Restenosis in Patients with MASLD." Journal of the Society for Cardiovascular Angiography & Interventions 4, no. 5 (2025): 103231. https://doi.org/10.1016/j.jscai.2025.103231.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jayaraj, Arjun, Robert Fuller, and Seshadri Raju. "Role of laser ablation in recalcitrant instent restenosis post iliofemoral venous stenting." Journal of Vascular Surgery Cases, Innovations and Techniques 7, no. 2 (2021): 298–301. http://dx.doi.org/10.1016/j.jvscit.2021.03.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Amritphale, Amod. "Are Biodegradable Third Generation Drug Eluting Stents the Answer to Instent Restenosis?" Cardiology and Angiology: An International Journal 2, no. 1 (2014): 15–40. http://dx.doi.org/10.9734/ca/2014/9138.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Mews, Geoffrey C., Geoffrey D. Cope, Richard A. Fox, et al. "A random placebo controlled trial of intracoronary RHENIUM-188 for instent restenosis." Heart, Lung and Circulation 12, no. 2 (2003): A97—A98. http://dx.doi.org/10.1046/j.1443-9506.2003.03672.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Lee, Wei-Chieh. "TCT-406 The Predictors of Instent Restenosis Again After Drug Eluting Balloon." Journal of the American College of Cardiology 66, no. 15 (2015): B164—B165. http://dx.doi.org/10.1016/j.jacc.2015.08.420.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Timizheva, K. B., A. V. Aghajanyan, L. V. Tskhovrebova, Z. Kh Shugushev, and M. M. Azova. "Assessment of the role of IL6 and IL10 gene polymorphisms as a risk factor for the development of restenosis in patients after implantation of drug-eluting stents." RUDN Journal of Medicine 25, no. 1 (2021): 48–54. http://dx.doi.org/10.22363/2313-0245-2021-25-1-48-54.

Full text

Abstract:

Relevance. Currently, the number of percutaneous coronary interventions continues to increase, which leads to an increase in the absolute number of restenosis cases, which is the main complication of the long-term postoperative period. The search for risk factors responsible for restenosis and artery re-narrowing mechanisms in order to prevent this complication is an important goal in interventional cardiology. Risk factors for the restenosis development include clinical, angiographic and genetic factors. An active search for biomolecular markers associated with the coronary artery restenosis

APA, Harvard, Vancouver, ISO, and other styles

22

Schillinger, Martin. "How to treat recurrent renal artery instent restenosis? Editorial comment on treatment of reoccuring instent restenosis following reintervention after stent-supported renal artery angioplasty–Article by Zeller et al." Catheterization and Cardiovascular Interventions 70, no. 2 (2007): 301–2. http://dx.doi.org/10.1002/ccd.21294.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Kaplan, Sahin, Peter Barlis, Jun Tanigawa, Omer Goktekin, and Carlo Di Mario. "Unconventional treatment of aorto-ostial instent restenosis with marked protrusion into the aorta." Journal of Cardiovascular Medicine 9, no. 2 (2008): 184–86. http://dx.doi.org/10.2459/jcm.0b013e3280126208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Jensen, L. O., P. Thayssen, J. F. Lassen, et al. "Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention." European Heart Journal 28, no. 15 (2007): 1820–26. http://dx.doi.org/10.1093/eurheartj/ehm067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Mehran, Roxana, Gary S. Mintz, Jeffrey J. Popma, et al. "Excimer laser angioplasty in the treatment of instent restenosis: An intravascular ultrasound study." Journal of the American College of Cardiology 27, no. 2 (1996): 362. http://dx.doi.org/10.1016/s0735-1097(96)82364-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ghoshal, A., and A. Mishra. "Outcomes of drug eluting balloon in native coronaries & venous graft instent restenosis." Heart, Lung and Circulation 24 (2015): S158. http://dx.doi.org/10.1016/j.hlc.2015.06.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Zeller, Thomas, Sebastian Sixt, Aljoscha Rastan, et al. "Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty." Catheterization and Cardiovascular Interventions 70, no. 2 (2007): 296–300. http://dx.doi.org/10.1002/ccd.21170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Böhme, Tanja, Elias Noory, Ulrich Beschorner, et al. "Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions (PHOTOPAC)." Vasa 50, no. 5 (2021): 387–93. http://dx.doi.org/10.1024/0301-1526/a000959.

Full text

Abstract:

Summary: Background: To evaluate the safety and effectiveness of preparing instent femoropopliteal lesion with photoablative laser atherectomy or plain balloon angioplasty (POBA) prior to drug-coated balloon (DCB) angioplasty. Patients and methods: The prospective, multicenter, randomized study enrolled patients with Rutherford-Becker-class (RBC) 1 to 5 and instent lesions located in superficial femoral artery and/or popliteal artery above the knee joint. Primary endpoint was target lesion percent stenosis at 1 year as determined by the angiographic core-laboratory. Secondary endpoints include

APA, Harvard, Vancouver, ISO, and other styles

29

Sakai, Hidetsugu, Naotsugu Oyama, Noriaki Kishimoto, Masashige Takahashi, Kazushi Urasawa, and Hiroyuki Tsutsui. "Revascularization of Malignant Coronary Instent Restenosis Resulting From Takayasu's Arteritis Using Sirolimus-Eluting Stents." International Heart Journal 47, no. 5 (2006): 795–801. http://dx.doi.org/10.1536/ihj.47.795.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Xu, Jack, Michael S. Cross, Swetal Patel, and Subhi Jamal Alaref. "UTILIZING SHOCKWAVE THERAPY FOR THE TREATMENT OF RECURRENT INSTENT RESTENOSIS AND SIGNIFICANT CORONARY CALCIFICATION." Journal of the American College of Cardiology 79, no. 9 (2022): 2284. http://dx.doi.org/10.1016/s0735-1097(22)03275-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Taniwaki, Masanori, Keiichi Onishi, Hirotaka Ezaki, et al. "PERFORMANCE OF ULTRA-HIGH RESOLUTION CT OF INSTENT RESTENOSIS OF BELOW 3.0MM CORONARY STENT." Journal of the American College of Cardiology 75, no. 11 (2020): 1629. http://dx.doi.org/10.1016/s0735-1097(20)32256-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Mahdi, N. "PTCA, Directional and Rotational Coronary Atherectomy in the Management of Palmaz-Schatz Instent Restenosis." Journal of the American College of Cardiology 31, no. 2 (1998): 275A. http://dx.doi.org/10.1016/s0735-1097(97)84905-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Swinnen, Jan “John”, Kerry Hitos, Lukas Kairaitis, et al. "Multicentre, randomised, blinded, control trial of drug-eluting balloon vs Sham in recurrent native dialysis fistula stenoses." Journal of Vascular Access 20, no. 3 (2018): 260–69. http://dx.doi.org/10.1177/1129729818801556.

Full text

Abstract:

Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in the treatment of recurrent haemodialysis fistula stenosis. Methods: This is a randomised, controlled, investigator-initiated and run, prospective, blinded, multicentre trial. Patients with recurrent autogenous arteriovenous haemodialysis fistula stenosis received standard endovascular treatment plus drug-eluting balloon or standard endovascular treatment plus uncoated balloon (Sham). Primary endpoint was late lumen lo

APA, Harvard, Vancouver, ISO, and other styles

34

Chandrasekar, Baskaran, Martin Sirois, Pascale Geoffroy, Dominique Lauzier, Stanley Nattel та Jean-François Tanguay. "Local delivery of 17β-estradiol improves reendothelialization and decreases inflammation after coronary stenting in a porcine model". Thrombosis and Haemostasis 94, № 11 (2005): 1042–47. http://dx.doi.org/10.1160/th04-12-0823.

Full text

Abstract:

SummaryIn the current study, we investigated the effect of local intravascular delivery of 17β-estradiol (17β-E) on subsequent instent neointimal hyperplasia. Twenty-seven stents were implanted in coronary arteries of juvenile swine. Coronary arteries were randomized to local treatment with 17β-E or no drug therapy (control-vehicle treated). Twenty-eight days posttreatment, angiographic images revealed an improved minimal lumen diameter (2.2 ± 0.2 vs. 1.3 ± 0.2 mm, P < 0.005) and a reduction of late lumen loss (1.7 ± 0.2 vs. 2.3 ± 0.1 mm, P < 0.01) in 17β-E-treated vessels compared to co

APA, Harvard, Vancouver, ISO, and other styles

35

Liang, Dongke, Da Zhi Yang, Min Qi, and Wei Qiang Wang. "Finite Element Analysis of a Stent Implantation in a Stenosed Artery." Key Engineering Materials 288-289 (June 2005): 571–74. http://dx.doi.org/10.4028/www.scientific.net/kem.288-289.571.

Full text

Abstract:

Instent restenosis (ISR) has been a key factor that restricts the further use of intraoronary stents. And the mechanical interaction between the stent and the artery has been indicated as one of the significant causes for the activation of stent-related restenosis. However, there is very little quantitative information about the interaction of stent with artery. In order to improve the general understanding of coronary stenting, finite element method (FEM) has been used to model the revascularization of a stenosed artery through the insertion of a balloon-expandable stent. Given a stent design

APA, Harvard, Vancouver, ISO, and other styles

36

Sadato, A., W. Taki, N. Sakai, et al. "Initial Experiences of Carotid Stenting with Palmaz Stent." Interventional Neuroradiology 5, no. 1_suppl (1999): 33–35. http://dx.doi.org/10.1177/15910199990050s105.

Full text

Abstract:

Results of cervical carotid stenting are reported. Twenty-nine lesions in 25 cases were treated by percutaneous transluminal balloon angioplasty combined with stent placement. All the lesions were successfully dilated. There was one embolic complication during the operation that caused deterioration of preoperative symptoms. Stent deformation causing more than 30% luminal narrowing occurred in one case. Instent restenosis with more than 50% luminal narrowing was seen in bilateral lesions in one case. These were satisfactory results as an initial experience, but further improvement in this tech

APA, Harvard, Vancouver, ISO, and other styles

37

YIN, Yu-gang, and Bin WANG. "Effects of rosuvastatin on instent restenosis, plasma lipid level and inflammatory factors after coronary stenting." Academic Journal of Second Military Medical University 31, no. 2 (2011): 227–28. http://dx.doi.org/10.3724/sp.j.1008.2011.00227.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Jayaraj, Arjun, and Seshadri Raju. "Utility of a Mechanical Thrombectomy Device in Treating Calcified Instent Restenosis Post Iliofemoral Venous Stenting." Annals of Vascular Surgery 79 (February 2022): 443.e1–443.e5. http://dx.doi.org/10.1016/j.avsg.2021.08.020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Wei, X., Y. Zheng-Bai, S. Zhen-Qi, and H. Hong-Hua. "Influence of the level of HB-EGF in serum on instent restenosis after CHD stenting." Heart 97, Suppl 3 (2011): A167. http://dx.doi.org/10.1136/heartjnl-2011-300867.495.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Varenhorst, Christoph, Giovanna Sarno, Kristina Hambraeus, et al. "SCAAR: CHANGES IN DRUG ELUTING STENT USE AND INSTENT-RESTENOSIS RATES FROM 2002 TO 2012." Journal of the American College of Cardiology 63, no. 12 (2014): A1902. http://dx.doi.org/10.1016/s0735-1097(14)61905-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Chua, Dave C. Y., Francis Q. Almeda, Shaun Senter та ін. "Visual assessment of procedural results following treatment with Sr-90 β-radiation for instent restenosis". Cardiovascular Radiation Medicine 3, № 3-4 (2002): 133–37. http://dx.doi.org/10.1016/s1522-1865(03)00102-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Chua, Dave C. Y., Francis Q. Almeda, Shaun Senter та ін. "Predictors of late cardiac events following treatment with Sr-90 β-irradiation for instent restenosis". Cardiovascular Radiation Medicine 4, № 1 (2003): 7–11. http://dx.doi.org/10.1016/s1522-1865(03)00117-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Lin, Chia-Chang, and Jun-Ting Liou. "TCTAP C-058 Severe BMS-Instent Restenosis Treated by Cutting & Drug-coated Balloon Dilatations." Journal of the American College of Cardiology 73, no. 15 (2019): S128—S129. http://dx.doi.org/10.1016/j.jacc.2019.03.246.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Montrivade, Sakolwat. "TCTAP C-083 Solving Recalcitrant Instent Restenosis With Combined Laser Atherectomy and Shockwave Intravascular Lithotripsy." Journal of the American College of Cardiology 83, no. 16 (2024): S175—S177. http://dx.doi.org/10.1016/j.jacc.2024.03.190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Zhou, Sheng-Nan, Le Yang, Bi-Yang Feng, Lei Liu, and Li-Ming Chen. "In-Stent Restenosis: Achilles’ Heel of Post-PCI Era." Journal of Clinical Cardiology 5, no. 1 (2024): 1–5. http://dx.doi.org/10.33696/cardiology.5.047.

Full text

Abstract:

Despite advancements in stent design and polymer coatings over the past two decades, 1% to 2% of patients annually still experience instent restenosis (ISR). ISR reduces myocardial perfusion, may develop symptoms of myocardial ischemia, and thus leads to a high risk of myocardial infarction and cardiac death. Given that millions of drug-eluting stents (DES) are implanted globally every year, ISR remains a prevalent clinical issue with significant public health implications. Coronary intravascular imaging, includes intravascular ultrasound (IVUS) and optical coherence tomography (OCT), can help

APA, Harvard, Vancouver, ISO, and other styles

46

Skoczyńska, Agnieszka, Andrzej Ochała, Sebastian Dworowy, and Michał Tendera. "Drug eluting stent or drug eluting balloon? Which is the better device to treat instent restenosis?" Advances in Interventional Cardiology 2 (2011): 147–55. http://dx.doi.org/10.5114/pwki.2011.23167.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Heck, D. "033 Incidence and time course of carotid instent restenosis in a consecutive series of 295 patients." Journal of NeuroInterventional Surgery 1, no. 1 (2009): 86–87. http://dx.doi.org/10.1136/jnis.2009.001016g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Fujiu, Katsuhito, Ichiro Manabe, Yumiko Oishi, Kensuke Tsushima, Go Nishimura, and Ryozo Nagai. "ADMINISTRATION OF AM80 INHIBITED INSTENT RESTENOSIS BY MODULATING SMOOTH MUSCLE CELL PHENOTYPE IN VITRO AND VIVO." Cardiovascular Pathology 13, no. 3 (2004): 159. http://dx.doi.org/10.1016/j.carpath.2004.03.480.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Oruganti, Harish. "TCTAP C-110 Look Beyond What You See: Successful Oct Guided PCI of Lad Instent Restenosis." Journal of the American College of Cardiology 85, no. 15 (2025): S262—S265. https://doi.org/10.1016/j.jacc.2025.03.261.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rittger, H., M. Waliszewski, J. Woehrle, et al. "Prediction of therapy failure after treatment of instent-restenosis of drug-eluting stents with drug coated balloons." European Heart Journal 34, suppl 1 (2013): P4801. http://dx.doi.org/10.1093/eurheartj/eht310.p4801.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!